Comparative effectiveness of bisphosphonate treatments for the prevention of re-fracture in glucocorticoid-induced osteoporosis: protocol for a systematic review and meta-analysis. [PDF]
BMJ Open, 2022 Chu H +6 more
europepmc +1 more source
Use of bmps as a treatment for medication-related maxillary osteonecrosis (mronj): a systematic review. [PDF]
Acta Odontol ScandHernando-Calzado L +5 more
europepmc +1 more source
Correction: Association of dietary patterns with osteoporosis risk: a meta-analysis of observational studies. [PDF]
J Orthop Surg ResTan B, Su H, Wei L, Liang M.
europepmc +1 more source
Clinical experiences with bisphopsphonate induced osteochemonecrosis of the jaws
Swiss Medical Weekly, 2006 C Dannemann, R Zwahlen
doaj +1 more source
Increased Prevalence of Periapical Lesions in Osteoporosis Patients: A Systematic Review. [PDF]
Eur Endod JRodrigues Freitas G +7 more
europepmc +1 more source
Biphosphonate and Jaws Osteonecrosis. Considerations About of Treatment
, 2015 Bisphosphonates are strong osteoclastic inhibitor activities, being these drugs usually for treatment of multiple myeloma and bone metastases of solid tumors like breast cancer. The osteonecrosis of the maxillary bones was first described in 2003.
Barbosa, JRDA +4 more
core
Delayed Diagnosis of Suspected Osteogenesis Imperfecta in a Young Adult with Recurrent Low-Energy Fractures: A Case Report. [PDF]
CureusDrari S, Baba Z, Mougui A, El Bouchti I.
europepmc +1 more source
Aspects of Polypharmacy in Dental Treatment of Seniors. [PDF]
Contemp Clin DentSantalucia G +4 more
europepmc +1 more source
Parathyroid Crisis: A Case of Elective Parathyroidectomy. [PDF]
Cureus, 2023 Adeniran U, Ji B, Hussein I, Soni L.
europepmc +1 more source
Lung function in adult patients with osteogenesis imperfecta: a cohort study. [PDF]
Orphanet J Rare DisLenoir A +7 more
europepmc +1 more source